In addition, GPR18 is closely co-expressed with several cytotoxic CD8+ T-cell markers in 28/29 cancer types (Supplementary Figs. 6 and 7), indicating that GPR18-expressing TIL-B-cells may be specifically linked to cytotoxic T-cell functions across human cancers. Here, CD8A is linked to cancer.